Manufacturing and QC - ProtaGene

Biologic Drug Analytics

Manufacturing and QC

hero-animation

Biologics Manufacturing and QC

Early strategic approaches and the application of advanced analytics before critical stages can improve product development, manufacturing, and clinical outcomes. ProtaGene offers industry-leading strategies, state-of-the-art analytic platforms run under GMP quality systems, and specialized expertise across both Europe and the US to help advance your manufacturing and product-facing analytical programs such as:

  • bullet Created with Sketch.

    Manufacturing and process analytics

  • bullet Created with Sketch.

    Method development

  • bullet Created with Sketch.

    Phase appropriate validation

  • bullet Created with Sketch.

    QC-lot release

  • bullet Created with Sketch.

    Stability program management

  • bullet Created with Sketch.

    Analytical life cycle management

Analytical Solutions from Research to Market

Group Created with Sketch.
Research
Preclinical
Group 2 Created with Sketch.

Discovery – Pre-clinical

Biologic Candidate Evaluation, Optimization and Selection into IND

Group 3 Created with Sketch.
Phase I
Phase II
Phase III
Group 4 Created with Sketch.

Phase I – Phase III

Release, Clinical Data and Characterization Packages for Accelerating Phase I-III Programs through BLA

Group Created with Sketch.
Registration
Market
Group 2 Created with Sketch.

Registration – Market

Commercial-Stage Comparability Testing by Qualified Advanced Methods

Biologic Therapeutics Platform Expertise

Our deep experience advancing a diverse range of therapeutic platforms from research through market help the ProtaGene team design highly effective analytical programs that de-risk development and accelerate timelines to your next key milestones. Key biologic development areas include:

  • bullet Created with Sketch.

    Recombinant proteins—including complex, highly glycosylated proteins

  • bullet Created with Sketch.

    Multi-subunit complexes—protein, nucleotide, ligand

  • bullet Created with Sketch.

    mAbs

  • bullet Created with Sketch.

    ADCs and protein conjugates

  • bullet Created with Sketch.

    PEGylated proteins

  • bullet Created with Sketch.

    Bispecifics/multispecifics

  • bullet Created with Sketch.

    Fusion proteins

  • bullet Created with Sketch.

    Enzyme replacement therapies

  • bullet Created with Sketch.

    Biosimilars

  • bullet Created with Sketch.

    Vaccines, including subunit/recombinant

Our Analytical Systems_Left Created with Sketch.

Analytical Systems

Enabled by state-of-the-art technology, ProtaGene offers an extensive range of analytical capabilities to support your biotherapeutic or gene & cell therapy projects.

Our Analytical Systems_right Created with Sketch.

Subscribe to Our Email List

Consent

Talk to Our Experts

Discover how ProtaGene can support your development programs

Contact Us